Induction Treatment with Rabbit Antithymocyte Globulin versus Basiliximab in Renal Transplant Recipients with Planned Early Steroid Withdrawal - Concepedia

Concepedia

Publication | Closed Access

Induction Treatment with Rabbit Antithymocyte Globulin versus Basiliximab in Renal Transplant Recipients with Planned Early Steroid Withdrawal

21

Citations

19

References

2011

Year

Spencer T. Martin, Keri Roberts, Sayeed K. Malek, Stefan G. Tullius, Nidyanandh Vadivel, Sacha De Serres, Mónica Grafals, Abdelaziz Elsanjak, Beth Anne Filkins, Anil Chandraker,

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy

Abstract

Rabbit-ATG was associated with a lower frequency and delayed onset of BPAR compared with basiliximab in renal transplant recipients who received an ESW regimen.

References

	Year	Citations

Page 1